Illumina price target lowered to $225 from $265 at Stifel

Stifel lowered the firm’s price target on Illumina to $225 from $265 and keeps a Buy rating on the shares. While stating it is “not difficult to understand” why consumables demand would be softer, it is “also not difficult to feel nervous about the impact of the lower sequencing pricing” amid end market conditions that “do not allow for much in the way of scaling volume or elasticity,” the analyst tells investors in a post-earnings note.